AlphaMadera's AlphaVal page computes Kodiak Sciences Inc.'s fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag KOD as undervalued, fairly valued, or overvalued.

What is Kodiak Sciences Inc.'s fair value?

Fair value for KOD is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value KOD?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from KOD's most recent reported fundamentals.

KOD - Kodiak Sciences Inc.

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $63.75 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

AlphaVal Unavailable

AlphaVal: KOD has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.